Visual Hallucinations During Hepatitis C Treatment With Sofosbuvir and Simeprevir: A Case Report

    loading  Checking for direct PDF access through Ovid

Abstract

Direct-acting antiviral agents for hepatitis C treatment are not expected to have the neuropsychiatric adverse effects as sociated with interferon-based therapies. We present the first case of visual hallucinations during chronic hepatitis C treatment with sofosbuvir and simeprevir. Hallucinations ceased upon starting antipsychotic medication, and continuation of treatment was safe.

Related Topics

    loading  Loading Related Articles